Thromboembolic Complications of Current Cardiac Valvular Prostheses

Annals of Thoracic Surgery

Volumn 34, Issue 1, 1982, Pages 96-106

  Edmunds, L Henry ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD AND HEMOPOIETIC SYSTEM; CARDIOVASCULAR SYSTEM; EMBOLISM; HEART; HEART VALVE PROSTHESIS; SHORT SURVEY; THERAPY; THROMBOSIS;

EID: 0019976468     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(10)60862-4     Document Type: Review

References (63)

1. The ultimate prognosis after valve replacement: an assessment at twenty years
2. Arterial thromboembolic complications in patients with Björk-Shiley and Lillehei-Kaster tilting disc valve prostheses
3. Thromboembolic complications of the cloth-covered Starr-Edwards prosthesis No. 2300 aortic and No. 6300 mitral
4. Thrombotic complications after valve replacement with porcine heterografts
5. Arterial thromboembolic complications in patients with Starr-Edwards aortic ball valve prostheses
6. Mitral valve replacement with the Smeloff-Cutter prosthesis
7. Survival after Starr-Edwards aortic valve replacement
8. Thromboembolic complications of heart valve prostheses
9. Mitral valve replacement: a 10-year follow-up of non-cloth-covered vs cloth-covered caged-ball prostheses
10. Long-term evaluation of the porcine xenograft biopros-thesis
11. Hemorrhagic complications of anticoagulant therapy
12. Long-term follow-up of isolated replacement of the aortic or mitral valve with the Starr-Edwards prosthesis
13. Isolated replacement of the mitral valve with the Starr-Edwards prosthesis
14. Ten years' experience with the Björk-Shiley tilting disc valve
15. Ten-year follow-up in aortic valve replacement using the Björk-Shiley prosthesis
16. Five-year experience with the Smeloff-Cutter mitral prosthesis
17. Late results of Lillehei-Kaster valve
18. Long-term survival after simple aortic or mitral valve replacement with the present model of Smeloff-Cutter valve
19. Thromboembolic complications of prosthetic cardiac valves
20. Intracranial hemorrhage and infarction in anticoagulated patients with prosthetic heart valves
21. Warfarin therapy
22. Drug interactions with coumarin anticoagulant
23. Obstruction of tricuspid ball-valve prostheses
24. Tricuspid valve prosthetic replacement
25. Ball valve prosthesis: current appraisal of late results
26. Aortic valve replacement: a ten-year follow-up of non-cloth vs cloth-covered caged-ball prostheses
27. Clinical evaluation of the Lillehei-Kaster pivoting-disc valve
28. Thrombosis of the Björk-Shiley aortic valve prosthesis
29. Anticoagulants and the Björk-Shiley prosthesis
30. Thrombosed Björk-Shiley mitral prostheses
31. Thrombosis on Björk-Shiley aortic valve prosthesis
32. Late thrombosis of the aortic Björk-Shiley prosthesis
33. Results of valve replacement with the Lillehei-Kaster disc prosthesis
34. Clinical experience with the Lillehei-Kaster cardiac valve prosthesis
35. Long-term results of “simple” thrombectomy for thrombosed Björk-Shiley aortic valve prostheses
36. Long-term clinical and hemodynamic evaluation of the Ionescu-Shiley pericardial xenograft heart valve
37. Medium-term follow-up of the Ionescu-Shiley heterograft valve
38. The Starr-Edwards Model 6000 valve
39. Year of operation as a risk factor in the late results of valve replacement
40. Five to eight-year follow-up of patients undergoing porcine heart-valve replacement
41. Tissue valve replacement of prosthetic heart valves for thromboembolism
42. Experience with the Carpentier-Edwards porcine valve prosthesis in 700 patients
43. Incidence of emboli with cloth-covered Starr-Edwards valve without anticoagulation and with varying forms of anticoagulation
44. Living with prosthetic heart valves: subsequent non-cardiac operations and the risk of thromboembolism or hemorrhage
45. Control of thromboembolism from prosthetic heart valves
46. Thromboembolic complications with the cloth-covered Starr-Edwards aortic prosthesis in patients not receiving anticoagulants
47. Thromboembolic phenomena in patients with prosthetic aortic valves who did not receive anticoagulants
48. Thrombotic phenomena with non-anticoag-ulated, composite-strut aortic prostheses
49. Incidence of thromboembolism after stopping anticoagulant therapy
50. Aspirin and prophylaxis of thromboembolic complications in patients with substitute heart valves
51. Combined warfarin-platelet inhibitor antithrombotic therapy in prosthetic heart valve replacement
52. Pharmacologic control of thrombotic complications of cardiac-valve replacement
53. Prevention of arterial thromboembolism with acetylsalicylic acid
54. Current status of porcine heterograft prostheses
55. Aortic valve replacement
56. Bioprosthetic cardiac valves—anticoagulation or not
57. Thromboembolism in mitral porcine recipients
58. Ionescu-Shiley pericardial xenograft valve: hemodynamic evaluation and early clinical follow-up of 326 patients
59. Long-term survival of the aortic valve replacement using Smeloff-Cutter prosthesis
60. Clinical experience with the Lillehei-Kaster valve prosthesis
61. Clinical and hemodynamic results with the St. Jude Medical cardiac valve prosthesis: a three-year experience
62. Long-term follow-up of the Björk-Shiley prosthetic valve used in the mitral position